A novel selective and orally bioavailable Nav1.8 channel blocker, PF‐01247324, attenuates nociception and sensory neuron excitability

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|10|2654-2670

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.10, 2015-05, pp. : 2654-2670

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 4, 2018-02 ,pp. : 693-707

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inefficacy of a Highly Selective T‐Type Calcium Channel Blocker in Preventing Atrial Fibrillation Related Remodeling

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 25, Iss. 5, 2014-05 ,pp. : 531-536

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF‐06372865

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 4, 2018-02 ,pp. : 708-725

John Wiley & Sons Inc

Access to resources Recommend Favorite

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker

By Kuti Effie L.   Baker William L.   White C. Michael  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1239-1244

Informa Healthcare

Access to resources Recommend Favorite

Calcium Channel Blocker versus Angiotensin II Receptor Blocker in Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 99, Iss. 1, 2005-01 ,pp. : c18-c23

Karger

Access to resources Recommend Favorite